The case describes Rentosertib as the world’s first drug with both an AI-discovered target and an AI-designed molecular structure to enter Phase II human clinical trials, and uses that milestone to ...
Kerr, William. "Case Study: Do We Reskill or Replace Our Workforce?" Harvard Business Review 103, no. 4 (July–August 2025): 141–145.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results